About Us and Our Mission


Frontiers: The Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research,
providing support to scientists and involving the community, so that discoveries and research findings will be brought
more rapidly to the point of care, thus improving the health of all in the region.

The vision of Frontiers is to improve the health of the region by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our program are an entrepreneurial drug and device discovery and development program and a well-developed community-based research program. Funded by a $20 million Clinical and Translational Science Award from the National Institutes of Health and headquartered at the University of Kansas Medical Center, Frontiers works with its partner institutions around the region to bring new cures and therapies to patients faster.

Please see a welcome letter from our director, Richard J. Barohn, M.D.


  1. create a new academic home with training programs for clinical and translational investigators
  2. provide an enhanced coordinated translational research infrastructure
  3. actively engage the community in developing, testing, and disseminating translational research, by capitalizing on and expanding existing networks, to improve the health of all in the region—especially those in rural, underserved and other target communities. 

The infrastructure and educational programs of Frontiers address the challenges facing clinical and translational investigators by enhancing and integrating existing resources, developing new innovative resources, and capitalizing on resources residing in research centers across the university. Frontiers seeks to take laboratory discoveries to first trials in humans (T1 research) through to studies on dissemination and implementation of research findings to practice (T2 research).